EXOZYMES INC. Postemployment Benefits, Period Expense
EXOZYMES INC. (EXOZ) reported Postemployment Benefits, Period Expense of $43.51 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PostemploymentBenefitsPeriodExpense · last filed 2025-05-12
- EXOZYMES INC. postemployment benefits, period expense for the quarter ending 2025-03-31 was $43.51K, a 47.55% increase year-over-year.
- EXOZYMES INC. postemployment benefits, period expense for the quarter ending 2024-12-31 was $27.33K, a 17.53% decline year-over-year.
- EXOZYMES INC. postemployment benefits, period expense for the quarter ending 2024-03-31 was $29.49K.
- EXOZYMES INC. postemployment benefits, period expense for the quarter ending 2023-12-31 was $33.14K.
- EXOZYMES INC. postemployment benefits, period expense for fiscal 2024 was $111.34K, a 14.95% decline from fiscal 2023.
- EXOZYMES INC. postemployment benefits, period expense for fiscal 2023 was $130.91K.
| Period end | Postemployment Benefits, Period Expense 3 month | Postemployment Benefits, Period Expense 6 month | Postemployment Benefits, Period Expense 9 month | Postemployment Benefits, Period Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $43.51K 10-Q · filed 2025-05-12 | $70.84K derived: sum of 2 quarters · filed 2025-05-12 | ||
| 2024-12-31 | $27.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $111.34K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $84.00K 10-Q · filed 2024-11-12 | |||
| 2024-03-31 | $29.49K 10-Q · filed 2025-05-12 | $62.63K derived: sum of 2 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $33.14K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $130.91K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $97.77K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |